S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling.

作者: Chengshan Xu , Hongyan Chen , Xiang Wang , Jidong Gao , Yiqun Che

DOI: 10.1074/JBC.M113.469718

关键词:

摘要: HER2 is overexpressed in 20–25% of breast cancers. Overexpression an adverse prognostic factor and correlates with decreased patient survival. stimulates tumorigenesis via a number intracellular signaling molecules, including PI3K/AKT MAPK/ERK. S100A14, one member the S100 protein family, significantly associated outcome cancer patients. Here, for first time, we show that S100A14 are coexpressed invasive specimens, there significant correlation between expression levels two proteins by immunohistochemistry. colocalized plasma membrane tissue cells cell lines BT474 SK-BR3. We demonstrate binds directly to co-immunoprecipitation pull-down assays. Further study shows residues 956–1154 domain residue 83 essential binding. Moreover, observe decrease phosphorylation, downstream signaling, HER2-stimulated proliferation S100A14-silenced MCF-7, BT474, SK-BR3 cells. Our findings suggest functions as modulator provide mechanistic evidence its role progression.

参考文章(44)
Rikke Leth-Larsen, Mikkel G Terp, Anne G Christensen, Daniel Elias, Thorsten Kühlwein, Ole N Jensen, Ole W Petersen, Henrik J Ditzel, None, Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis Molecular Medicine. ,vol. 18, pp. 1109- 1121 ,(2012) , 10.2119/MOLMED.2012.00091
Jörg Klingelhöfer, Henrik D. Møller, Eren U. Sumer, Christian H. Berg, Maria Poulsen, Darya Kiryushko, Vladislav Soroka, Noona Ambartsumian, Mariam Grigorian, Eugene M. Lukanidin, Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein FEBS Journal. ,vol. 276, pp. 5936- 5948 ,(2009) , 10.1111/J.1742-4658.2009.07274.X
Yosef Yarden, Mark X. Sliwkowski, Untangling the ErbB signalling network Nature Reviews Molecular Cell Biology. ,vol. 2, pp. 127- 137 ,(2001) , 10.1038/35052073
Indraneel Mittra, Alka A. Redkar, Rajan A. Badwe, Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes Journal of Surgical Oncology. ,vol. 60, pp. 106- 111 ,(1995) , 10.1002/JSO.2930600208
Hong-Yan Zhang, Xian-Zhao Zheng, Xin-Hua Wang, Xiao-Yan Xuan, Feng Wang, Shan-Shan Li, S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity Molecular Biology Reports. ,vol. 39, pp. 199- 208 ,(2012) , 10.1007/S11033-011-0726-1
Chin-Sheng Yu, Yu-Ching Chen, Chih-Hao Lu, Jenn-Kang Hwang, Prediction of protein subcellular localization. Proteins. ,vol. 64, pp. 643- 651 ,(2006) , 10.1002/PROT.21018
Agnieszka Pietas, Karsten Schlüns, Ingo Marenholz, Beat W. Schäfer, Claus W. Heizmann, Iver Petersen, Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics. ,vol. 79, pp. 513- 522 ,(2002) , 10.1006/GENO.2002.6744
José Baselga, Sandra M. Swain, Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 Nature Reviews Cancer. ,vol. 9, pp. 463- 475 ,(2009) , 10.1038/NRC2656
Keisei Anan, Takashi Morisaki, Mitsuo Katano, Akashi Ikubo, Yasuhiro Tsukahara, Masayuki Kojima, Akihiko Uchiyama, Syoji Kuroki, Motomichi Torisu, Masao Tanaka, Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential Ejso. ,vol. 24, pp. 28- 33 ,(1998) , 10.1016/S0748-7983(98)80121-2